NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Solstice Pharmaceuticals

Solstice Pharmaceuticals

Private
EnschedeHealthcare & Life Scienceshttps://solsticepharma.com/

Last Round

Grant

Dec 12, 2025

Company Overview

Solstice Pharmaceuticals is a medical imaging company that develops, manufactures, and commercializes ultrasound contrast agents and related activation systems for diagnostic and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

specialty pharmaceuticalsorphan drugsrare disease therapiespharma acquisitionmedical, legal, and regulatoryMLRpharmaceutical commercializationAI marketing agencyvibe codingmetabolic disordersendocrine disorderssupply chain managementniche therapeuticslife sciences marketing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Solstice Pharmaceuticals Comparables

Compare Solstice Pharmaceuticals with similar companies based on industry and business-model similarity.

Solstice Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Microvascular Therapeutics, Inc.
38%
Triangle Biotechnology, Inc.
32%

Solstice Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 12, 2025
GrantJan 20, 2022
GrantJul 21, 2021
VC RoundJul 7, 2021

Solstice Pharmaceuticals Investors

Notable investors and investment history

Solstice Pharmaceuticals investors
InvestorRounds
High Tech FundsGrant
Netherlands Organization for Scientific ResearchGrant
Netherlands Enterprise AgencyGrant

Solstice Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Solstice Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Solstice Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersEnschede
Employee Range11
Year Founded2020
Last FundingDec 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.